Company Filing History:
2 out of 1,309 
1 out of 28 
1 out of 389 
Years Active: 2007-2012
Title: Joann Witek: Innovator in Antibody Research
Introduction
Joann Witek is a notable inventor based in Acton, MA (US), recognized for her contributions to the field of immunology. With a total of 3 patents, her work focuses on developing antibodies that target the human interleukin-21 receptor (IL-21R). These innovations have significant implications for treating various immune system disorders.
Latest Patents
Witek's latest patents include groundbreaking research on nucleic acids coding for antibodies against the human IL-21 receptor. The first patent describes human antibodies and antigen binding fragments that specifically bind to IL-21R. These antibodies can act as antagonists, modulating immune responses and potentially aiding in the diagnosis, treatment, or prevention of inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders. The second patent reiterates similar findings, emphasizing the therapeutic potential of these antibodies in addressing various health challenges.
Career Highlights
Throughout her career, Joann Witek has worked with prominent companies such as Wyeth and Cambridge Antibody Technology Limited. Her experience in these organizations has contributed to her expertise in antibody research and development.
Collaborations
Witek has collaborated with notable colleagues, including Deborah A Young and Matthew James Whitters. These partnerships have likely enhanced her research and innovation efforts in the field of immunology.
Conclusion
Joann Witek's contributions to antibody research and her innovative patents position her as a significant figure in the field of immunology. Her work continues to pave the way for advancements in treating immune system disorders.